LMAT

$86.28+7.05%visit website

LEMAITRE VASCULAR INC

Market Cap

$2.0B

Live price × SEC shares (Aug 2, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

0.51

60mo monthly vs SPY

P/E (TTM)

30.2

TTM to Jun 2026 · diluted EPS

P/S (TTM)

7.5

TTM to Jun 2026 · revenue

P/B

4.7

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	61,046	64,453	66,551	70,382	262,432
Cost of revenue	15,091	18,263	18,155	19,618	71,127
Gross profit	45,955	46,190	48,396	50,764	191,305
Research & development	2,970	3,533	4,060	4,847	15,410
Total operating expenses	25,643	27,358	30,621	30,365	113,987
Operating income	20,312	18,832	17,775	20,399	77,318
Interest expense	1,297	1,298	1,300	1,302	5,197
Pretax income	22,573	20,300	19,672	22,189	84,734
Income tax	5,211	4,718	3,993	5,139	19,061
Net income	17,362	15,582	15,679	17,050	65,673
EPS (basic) ($)	0.77		0.69	0.75	2.88
EPS (diluted) ($)	0.75		0.68	0.74	2.86
Weighted avg. shares (basic)	22,660		22,801	22,858
Weighted avg. shares (diluted)	24,392		23,031	24,531

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 5, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

8 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 15, 2026 accepted 8:11 PM ET	5.02Officer / director change	Document SEC ↗
Aug 4, 2026 accepted 8:39 PM ET	2.02Earnings release	Document SEC ↗
Jun 5, 2026 accepted 11:41 PM ET	5.07Shareholder vote	Document SEC ↗
May 5, 2026 accepted 8:34 PM ET	2.02Earnings release	Document SEC ↗
Apr 14, 2026 accepted 10:45 AM ET	5.02Officer / director change8.01Other events	Document SEC ↗
Feb 25, 2026 accepted 9:54 PM ET	2.02Earnings release	Document SEC ↗
Nov 7, 2025 accepted 2:00 AM ET	8-K/A 5.07Shareholder vote	Document SEC ↗
Nov 6, 2025 accepted 9:03 PM ET	2.02Earnings release	Document SEC ↗
Aug 5, 2025 accepted 8:22 PM ET	2.02Earnings release	Document SEC ↗
Jun 3, 2025 accepted 9:01 PM ET	5.07Shareholder vote	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

40%

W/W -3.7pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-05-08	2026-05-11	LeMaitre George W	Director & Chairman and CEO	Sale	27.9K	$108.69	$3.03M	1.43M	View
2026-05-08	2026-05-11	Kamke Trent G	Senior V. P., Operations	Sale	2,928	$107.00	$313K	3,749	View
2026-05-07	2026-05-11	Ross Bridget A	Director	Sale	5,044	$111.10	$560K	3,942	View
2026-05-07	2026-05-11	Jasinski Lawrence J	Director	Sale	3,943	$110.00	$434K	4,714	View
2026-05-07	2026-05-11	LeMaitre George W	Director & Chairman and CEO	Sale	18.6K	$107.64	$2.00M	1.46M	View

1–5 of 12

1 / 3

Recent News

LeMaitre Vascular (NASDAQ:LMAT) Stock Crosses Above 50-Day Moving Average - Time to Sell?

MarketBeat · 2026-11-03

LeMaitre earnings: what to look for from LMAT

FinancialContent · 2026-11-03

LeMaitre Vascular, Inc. (LMAT) Stock Forecasts

Yahoo! Finance Canada · 2026-11-02

Dividend Income Report: +15.25% And A Listener's Portfolio Roast

SeekingAlpha · 2026-10-31

3 cash-heavy stocks walking a fine line

Yahoo · 2026-10-22

LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026

Yahoo · 2026-10-12

LeMaitre Vascular (NASDAQ:LMAT): A Quality Stock for Long-Term Investors

ChartMill · 2026-10-09

1 of Wall Street’s Favorite Stocks to Own for Decades and 2 We Brush Off

Yahoo · 2026-10-06

LeMaitre Vascular (LMAT) Stock Looks Priced Above Its Cash Flow Value

Simply Wall St · 2026-09-24

LeMaitre Vascular (LMAT) Stock Looks Fully Priced On Its 57% Five Year Run

Yahoo Finance · 2026-09-24

2 Profitable Stocks to Target This Week and 1 We Ignore

Yahoo Finance · 2026-09-21

Speculative Rally Weighed on LeMaitre Vascular (LMAT)

Yahoo Finance · 2026-09-01

LeMaitre to Participate at Upcoming Investor Conferences in September

Yahoo Finance · 2026-08-27

The Top 5 Analyst Questions From LeMaitre’s Q2 Earnings Call

Yahoo Finance · 2026-08-13

LeMaitre Vascular: 31% Drawdown On $0.02 Guidance Cut (NASDAQ:LMAT)

Seeking Alpha · 2026-08-13

Informational purposes only, not investment advice.

LMAT

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

LEMAITRE VASCULAR INC (LMAT)

Reporting Insiders

Factor Profile

Corporate Events (8-K)

Date	Insider	Type	Shares	Value
2026-05-08	LeMaitre George W	S	27,881	$3M
2026-05-08	Kamke Trent G	S	2,928	$313,286.92
2026-05-07	Ross Bridget A	S	5,044	$560,366.21
2026-05-07	Jasinski Lawrence J	S	3,943	$433,730
2026-05-07	LeMaitre George W	S	18,600	$2M